Key facts
- Notable investors include LRVHealth.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Prism TPO
- ·The full record, as it builds
Funding rounds
No funding rounds for Prism TPO are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Prism TPO
Provider of healthcare drug purchasing services designed for oncology medication procurement. The company's platform connects independent oncology practices with pharmaceutical manufacturers, offers simplified and transparent drug pricing structures, and facilitates purchasing through negotiated agreements, enabling medical practices to manage drug acquisition costs and procurement processes.
- Sector
- Healthcare
- HQ
- Nashville, TN, United States
- Founded
- 2024
- Employees
- 8
- Website
- prismtpo.com/
- Ownership
- Privately Held (backing)
Prism TPO doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Prism TPO shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Prism TPO in its N-PORT filings yet. We sweep new filings monthly.